Acetyl-CoA carboxylase α is essential to breast cancer cell survival

Cancer Research

Volumn 66, Issue 10, 2006, Pages 5287-5294

  Chajès, Véronique ^a   Cambot, Marie ^a   Moreau, Karen ^a   Lenoir, Gilbert M ^a   Joulin, Virginie ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ALPHA TOCOPHEROL; ANTIOXIDANT; BRCA1 PROTEIN; FATTY ACID SYNTHASE; MESSENGER RNA; PALMITIC ACID; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FATTY ACID SYNTHESIS; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HEREDITY; HUMAN; HUMAN CELL; LIPID COMPOSITION; LIPOGENESIS; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN INDUCTION; PROTEIN INTERACTION; RNA INTERFERENCE;

ACETYL-COA CARBOXYLASE; APOPTOSIS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; FATTY ACID SYNTHETASE COMPLEX; FATTY ACIDS; GENE SILENCING; HUMANS; LIPOGENESIS; PALMITIC ACID; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 33744808464     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-1489     Document Type: Article

References (34)

1. Menendez JA, Colomer R, Lupu R. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids? Med Hypotheses 2005;4:342-9.
2. Chajes V, Lanson M, Fetissof F, Lhuillery C, Bougnoux P. Membrane fatty acids of breast carcinoma: contribution of host fatty acids and tumor properties. Int J Cancer 1995;63:169-75.
3. Milgraum LZ, Witters LA, Pasternack GR, Kuhajda FP. Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin Cancer Res 1997;3:2115-20.
4. Alo PL, Viscera P, Trombetta G, et al. Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas. Tumori 1999;85:35-40.
5. Nakamura I, Kimijima I, Zhang GJ, et al. Fatty acid synthase expression in Japanese breast carcinoma patients. Int J Mol Med 1999;4:381-7.
6. Swinnen JV, Vanderhoydonc F, Elgamal AA, et al. Selective activation of the fatty acid synthesis pathway in human prostate cancer. Int J Cancer 2000;88:176-9.
7. Swinnen JV, Roskams T, Joniau S, et al. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int J Cancer 2002; 98:19-22.
8. Oskouian B. Overexpression of fatty acid synthase in SKBR3 breast cancer cell line is mediated via a transcriptional mechanism. Cancer Lett 2000;149:43-51.
9. Yang YA, Morin PJ, Han WF, et al. Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c. Exp Cell Res 2003;282:132-7.
10. Graner L, Tang D, Rossi S, et al. The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. Cancer Cell 2004;5:253-61.
11. Kuhajda FP, Jenner K, Wood FD, et al. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci U S A 1994;91: 6379-83.
12. Pizer KS, Jackisch C, Wood FD, Pasternack GR, Davidson NK, Kuhajda FP. Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells. Cancer Res 1996;56:2745-7.
13. Pizer FS, Chrest FJ, DiGiuseppe JA, Han WF. Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res 1998;58:4611-5.
14. Pizer ES, Thupari J, Han WF, et al. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res 2000;60: 213-8.
15. Li JN, Gorospe M, Chrest FJ, et al. Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. Cancer Res 2001;61:1493-9.
16. Thupari JN, Pinn ML, Kuhajda FP. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity. Biochem Biophys Res Commun 2001; 285:217-23.
17. Zhou W, Simpson PJ, McFadden JM, et al. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. Cancer Res 2003;63:7330-7.
18. De Schrijver E, Brusselmans K, Heyns W, Verhoeven G, Swinnen JV. RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells. Cancer Res 2003;63: 3799-804.
19. Brusselmans K, De Schrijver E, Verhoeven G, Swinnen JV. RNA interference-mediated silencing of the acetyl-CoA-carboxylase-α gene induces growth inhibition and apoptosis of prostate cancer cells. Cancer Res 2005;65:6719-25.
20. Magnard C, Bachelier R, Vincent A, et al. BRCA1 interacts with acetyl-CoA carboxylase throuch its tandem of BRCT domains. Oncogene 2002;21:6729-39.
21. Travers MT, Cambot M, Kennedy HT, Lenoir GM, Barber MC, Joulin V. Asymmetric expression of transcripts derived from the shared promoter between the divergently orientated ACACA and TADA2L genes. Genomics 2005;85:71-84.
22. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000;6:513-9.
23. Pizer ES, Pflug BR, Bova GS, Han WF, Udan MS, Nelson JB. Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression. Prostate 2001;47:102-10.
24. Lavillonniere F, Chajes V, Martin JC, Sebedio JL, Lhuillery C, Bougnoux P. Dietary purified cis-9,trans-11 conjugated linoleic acid isomer has anticarcinogenic properties in chemically induced mammary tumors in rats. Nutr Cancer 2003;45:190-4.
25. Wright TC, Cant JP. McBride BW. Inhibition of fatty acid synthesis in bovine mammary homogenate by palmitic acid is not a detergent effect. J Dairy Sci 2002; 85:642-7.
26. Hochachka PW, Rupert JL, Goldenberg L, Gleave M, Kozlowski P. Going malignant: the hypoxia-cancer connection in the prostate. Bioessays 2002;24:749-57.
27. Hatzivassiliou G, Zhao F, Bauer DE, et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 2005;8:311-21.
28. Dutta A, Dutta S. Vitamin E and its role in the prevention of atherosclerosis and carcinogenesis: a review. J Am Coll Nutr 2003;22:258-68.
29. Stoll BA. Breast cancer and the Western diet: role of fatty acids and antioxidant vitamins. Eur J Cancer 1998; 34:1852-6.
30. Bougnoux P. n-3 polyunsaturated fatty acids and cancer. Curr Opin Clin Nutr Metab Care 1999;2:121-6.
31. Albright CD, Salganik RI, Van Dyke T. Dietary depletion of vitamin E, vitamin A. inhibits mammary tumor growth and metastasis in transgenic mice. J Nutr 2004;134:1139-44.
32. Chajes V, Hulten K, Van Kappel AL, et al. Fatty-acid composition in serum phospholipids and risk of breast cancer: an incident case-control study in Sweden. Int J Cancer 1999;83:585-90.
33. Saadatian-Elahi M, Toniolo P, Ferrari P, et al. Serum fatty acids and risk of breast cancer in a nested case-control study of the New York University Women's Health Study. Cancer Epidemiol Biomarkers Prev 2002; 11:1353-60.
34. Pala V, Krogh V, Muti P, et al. Erythrocyte membrane fatty acids and subsequent breast cancer: a prospective Italian study. J Natl Cancer Inst 2001;93:1088-95.